Ian Dunn to Immunohistochemistry
This is a "connection" page, showing publications Ian Dunn has written about Immunohistochemistry.
Connection Strength
0.393
-
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression. Pituitary. 2021 Jun; 24(3):359-373.
Score: 0.164
-
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget. 2016 Nov 22; 7(47):76565-76576.
Score: 0.123
-
Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status. J Neurooncol. 2021 Feb; 151(3):443-449.
Score: 0.041
-
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget. 2014 Sep 30; 5(18):8083-92.
Score: 0.027
-
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014 Feb; 46(2):161-5.
Score: 0.025
-
HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy? Eur J Cancer. 2004 Jan; 40(1):56-63.
Score: 0.013